☰

Paulette A. Zaki, Ph.D. - Publications

Affiliations: 
2000 University of California, Los Angeles, Los Angeles, CA 
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2005 Bryant CD, Zaki PA, Carroll FI, Evans CJ. Opioids and addiction: Emerging pharmaceutical strategies for reducing reward and opponent processes Clinical Neuroscience Research. 5: 103-115. DOI: 10.1016/J.Cnr.2005.08.006  0.664
2001 Zaki PA, Keith DE, Thomas JB, Carroll FI, Evans CJ. Agonist-, antagonist-, and inverse agonist-regulated trafficking of the delta-opioid receptor correlates with, but does not require, G protein activation. The Journal of Pharmacology and Experimental Therapeutics. 298: 1015-20. PMID 11504798  0.638
2000 Watabe AM, Zaki PA, O'Dell TJ. Coactivation of beta-adrenergic and cholinergic receptors enhances the induction of long-term potentiation and synergistically activates mitogen-activated protein kinase in the hippocampal CA1 region. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 5924-31. PMID 10934239 DOI: 10.1523/Jneurosci.20-16-05924.2000  0.361
2000 Evans CJ, Monteillet-Agius G, Saliminejad N, Zaki PA. Opiate drugs: 'guilt by association'. Molecular Psychiatry. 5: 122-3. PMID 10822333 DOI: 10.1038/Sj.Mp.4000739  0.414
2000 Zaki PA, Keith DE, Brine GA, Carroll FI, Evans CJ. Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation? The Journal of Pharmacology and Experimental Therapeutics. 292: 1127-34. PMID 10688632  0.68
1998 Keith DE, Anton B, Murray SR, Zaki PA, Chu PC, Lissin DV, Monteillet-Agius G, Stewart PL, Evans CJ, von Zastrow M. mu-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Molecular Pharmacology. 53: 377-84. PMID 9495801 DOI: 10.1124/Mol.53.3.377  0.746
1998 Zaki PA, Evans CJ. ORL-1: An awkward child of the opioid receptor family Neuroscientist. 4: 172-184. DOI: 10.1177/107385849800400313  0.727
1997 Gylys KH, Tran N, Magendzo K, Zaki P, Evans CJ. cAMP decreases steady-state levels of δ-opioid receptor mRNA in NG108- 15 cells Neuroreport. 8: 2369-2372. PMID 9243642 DOI: 10.1097/00001756-199707070-00053  0.583
1996 Monteillet-Agius G, Fein J, Phan T, Anton B, Lam H, Zaki P, Miotto K, Evans CJ. Regulation and distribution of members of the opioid receptor family. Proceedings of the Western Pharmacology Society. 39: 69-70. PMID 8895973  0.627
1996 Zaki PA, Bilsky EJ, Vanderah TW, Lai J, Evans CJ, Porreca F. Opioid receptor types and subtypes: the delta receptor as a model. Annual Review of Pharmacology and Toxicology. 36: 379-401. PMID 8725395 DOI: 10.1146/Annurev.Pa.36.040196.002115  0.728
1996 Keith DE, Murray SR, Zaki PA, Chu PC, Lissin DV, Kang L, Evans CJ, von Zastrow M. Morphine activates opioid receptors without causing their rapid internalization. The Journal of Biological Chemistry. 271: 19021-4. PMID 8702570 DOI: 10.1074/Jbc.271.32.19021  0.744
1994 von Zastrow M, Keith D, Zaki P, Evans C. Intracellular trafficking of epitope-tagged opioid receptors: Different effects of morphine and enkephalin Regulatory Peptides. 54: 315-316. DOI: 10.1016/0167-0115(94)90516-9  0.725
Show low-probability matches.